Navigation Links
Kerry to Expand Center of Excellence with New Cell Science Laboratory Serving Bio-Pharma Customers Globally
Date:1/31/2012

BELOIT, Wis., Jan. 31, 2012 /PRNewswire/ -- Kerry Ingredients & Flavours is expanding its customer center of excellence in Beloit, Wisconsin, to include a new Cell Science laboratory. Building on the success of its companion site in Almere, The Netherlands, the new Cell Science laboratory will incorporate state-of-the-art technologies and media supplementation expertise to engage globally with Kerry's bio-pharma customers and technology partners.

"The new Cell Science laboratory expands our Media Enhancement Services capabilities for Cell Culture, Vaccines, Microbial Fermentation, and Diagnostics. Additionally, this new research and applications center with leading R&D expertise will advance our ability to customize cell media supplements to meet the evolving needs of the bio-pharma market globally," stated Christopher Wilcox, Kerry's Director of R&D overseeing Cell Culture & Media Supplementation technologies.

Kerry is investing more than $10 million in the expansion of the Cell Science laboratory and Kerry customer center of excellence, which includes a consumer nutrition center, extensive flavor labs and product ideation and customer collaboration suites.

"Expanding our Cell Science laboratory in the Kerry center allows us to advance our media ingredients and supplements portfolio while capturing greater synergies with Kerry's extensive analytical, research, development and applications expertise," stated Edmond Scanlon, President of Kerry's pharma and bio-pharma ingredients business. "This ultimately helps us deliver greater innovation and overall value for customers."

The expansion is expected to be complete by August 2012 and will add nearly 50 new jobs and an additional 30,000 square feet to the existing 260,000 square foot facility.

About Kerry Ingredients & Flavours
A division of Kerry Group, Kerry Ingredients & Flavours develops, manufactures and delivers innovative taste systems, functional ingredients and integrated solutions for the global food, beverage and pharmaceutical markets.

Serving the global pharmaceutical and bio-pharma markets under the trade name Sheffield Bio-Science, Kerry provides bio-pharma customers with a renowned product portfolio of media supplements including the industry-preferred HyPeps, Hy-Soy, NZ Amines, Primatones and Hy-Yests; as well as innovative new products such as Sheffield rInsulin ACF, Sheff-CHO ACF, Sheff-Vax ACF and Hy-Express systems.

Additionally, Kerry offers the pharmaceutical and nutrition markets a high quality excipient product line. including pharma-grade lactose, tablet coatings and pharma flavors, as well as custom developed innovative ingredient solutions to help customers succeed in the ever changing global marketplace.

www.kerry.com 


'/>"/>
SOURCE Kerry Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PPD and VirtualScopics Expand Strategic Alliance for Medical Imaging Services
2. Interventional Spine, Inc. Announces FDA Clearance of its Opticage™ Expandable Interbody for Treatment of Degenerative Disc Disease
3. AMPAC Fine Chemicals Expands Into Controlled Substance Manufacturing
4. Sanovas Expands Headquarters and Opens Manufacturing Site
5. PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
6. CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits
7. Myoderm Expands International Capabilities
8. FDA Expands Use of Endovascular Graft to Treat Aortic Tears
9. School Health Corporation Acquires EnableMart to Expand Product Offering Into Schools
10. Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study
11. Brabender® Pharma USA, Inc. and Particle Sciences Cooperate to Expand Extrusion Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, Inc. ... genome editing, announced that the U.S. Food and ... New Drug (IND) application for SB-318, a single ... for Mucopolysaccharidosis Type I (MPS I). The SB-318 ... to initiate a Phase 1/2 clinical study (SB-318-1502) ...
(Date:2/8/2016)... , February 8, 2016 ... new report published by Allied Market Research titled, ... Opportunities and Forecasts, 2014-2020", estimates the world synthetic ... Nucleotide synthesis and sequencing technology segment would continue ... and software tools segment, collectively, held around half ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, PLC, ... eine Infografik mit dem Titel „Epilepsy Around ... mit der der Krankheit gegenüber ein größeres ... ermutigen soll, Medikamentenresistenz bei Epilepsie auf dem ... Diskussion zu machen. Mithilfe der neuen Infografik ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... 2016 , ... Discover the Rocky Mountain region’s longest running and impressive garden ... Attendees also get to see the most incredible gardens and home improvement experts that ... the Colorado Convention Center - 700 14th St. Denver CO, is an exciting event ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... share this important news! AHCC and the Home Health and Hospice ICD-10 Transition ... designee for official ICD coding guidance and clarifications, to address concerns over the ...
Breaking Medicine News(10 mins):